» Authors » Michael Boettcher

Michael Boettcher

Explore the profile of Michael Boettcher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 154
Citations 1507
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Renkert M, Gunter F, Mohr C, Maurer K, Klinke Petrowsky M, Boettcher M, et al.
Burns . 2024 Sep; 50(9):107206. PMID: 39317544
Background: Pediatric thermal injuries can have profound physical and psychological effects. Long-term care, including wound dressing selection, significantly impacts outcomes. This study compared treatment related variables and long-term results of...
12.
Zierke K, Boettcher M, Behrendt P, Najem S, Zapf H, Reinshagen K, et al.
Children (Basel) . 2024 Aug; 11(8). PMID: 39201933
Background: Abdominal tumors rarely occur in childhood but are associated with great psychological stress for patients and their families. Parents playing a central role in their children's treatment may experience...
13.
Elkrewi E, Al Abdulqader A, Khasanov R, Maas-Omlor S, Boettcher M, Wessel L, et al.
Biomolecules . 2024 Aug; 14(8). PMID: 39199380
Hirschsprung's disease (HSCR, incidence 1/5000 live births) is caused by the failure of neural crest-derived precursors to migrate, survive, proliferate, or differentiate during the embryonic development of the Enteric Nervous...
14.
Jank M, Boettcher M, Keijzer R
World J Pediatr Surg . 2024 Aug; 7(3):e000747. PMID: 39183804
Worldwide, 150 children are born each day with congenital diaphragmatic hernia (CDH), a diaphragmatic defect with concomitant abnormal lung development. Patients with CDH with large defects are particularly challenging to...
15.
Blum L, Vincent D, Boettcher M, Knopf J
Front Immunol . 2024 Aug; 15:1434281. PMID: 39104529
Necrotizing enterocolitis (NEC) is one of the most devasting diseases affecting preterm neonates. However, despite a lot of research, NEC's pathogenesis remains unclear. It is known that the pathogenesis is...
16.
Zlatar L, Knopf J, Singh J, Wang H, Munoz-Becerra M, Herrmann I, et al.
Cell Death Dis . 2024 Jul; 15(7):548. PMID: 39085192
Tuberculosis (TB) remains one of the top 10 causes of death worldwide and still poses a serious challenge to public health. Recent attention to neutrophils has uncovered unexplored areas demanding...
17.
Dolling M, Rahimli M, Pachmann J, Szep M, Al-Madhi S, Andric M, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064205
: In patients diagnosed with uncomplicated acute appendicitis (UAA), the absence of calcified deposits or stones, called appendicoliths, often leads to consideration of non-operative treatment (NOT), despite the notable treatment...
18.
Leyens J, Bo B, Heydweiller A, Schaible T, Boettcher M, Schroeder L, et al.
Early Hum Dev . 2024 Jul; 195:106074. PMID: 39024811
Purpose: Congenital diaphragmatic hernia (CDH) affects 1 in 3000-5000 newborns. In survivors, long-term complications include gastroesophageal reflux (GER), feeding difficulties, and failure to thrive. Data from the parents' perspective remain...
19.
Schlegel L, Werbrouck C, Boettcher M, Schlegel P
Front Immunol . 2024 Jul; 15:1383894. PMID: 38962014
Chimeric antigen receptor (CAR) T cell therapy has effectively complemented the treatment of advanced relapsed and refractory hematological cancers. The remarkable achievements of CD19- and BCMA-CAR T therapies have raised...
20.
Fritsch A, Meyer M, Blaustein R, Trujillo M, Kauh E, Roessig L, et al.
Clin Pharmacokinet . 2024 Jun; 63(6):751-771. PMID: 38916717
Vericiguat is an oral soluble guanylate cyclase stimulator and enhances the cyclic guanosine monophosphate pathway independently of nitric oxide as well as synergistically in normal- and low-nitric oxide conditions. This...